Using inorganic nanoparticles to fight fungal infections in the antimicrobial resistant era.

Autor: Huang T; Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC 3010, Australia., Li X; Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC 3010, Australia., Maier M; Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC 3010, Australia., O'Brien-Simpson NM; ACTV Research Group, Melbourne Dental School and The Bio21 Institute of Molecular Science and Biotechnology, The University of Melbourne, Parkville, VIC 3010, Australia., Heath DE; Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC 3010, Australia., O'Connor AJ; Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC 3010, Australia. Electronic address: a.oconnor@unimelb.edu.au.
Jazyk: angličtina
Zdroj: Acta biomaterialia [Acta Biomater] 2023 Mar 01; Vol. 158, pp. 56-79. Date of Electronic Publication: 2023 Jan 11.
DOI: 10.1016/j.actbio.2023.01.019
Abstrakt: Fungal infections pose a serious threat to human health and livelihoods. The number and variety of clinically approved antifungal drugs is very limited, and the emergence and rapid spread of resistance to these drugs means the impact of fungal infections will increase in the future unless alternatives are found. Despite the significance and major challenges associated with fungal infections, this topic receives significantly less attention than bacterial infections. A major challenge in the development of fungi-specific drugs is that both fungi and mammalian cells are eukaryotic and have significant overlap in their cellular machinery. This lack of fungi-specific drug targets makes human cells vulnerable to toxic side effects from many antifungal agents. Furthermore, antifungal drug resistance necessitates higher doses of the drugs, leading to significant human toxicity. There is an urgent need for new antifungal agents, specifically those that can limit the emergence of new resistant species. Non-drug nanomaterials have primarily been explored as antibacterial agents in recent years; however, they are also a promising source of new antifungal candidates. Thus, this article reviews current research on the use of inorganic nanoparticles as antifungal agents. We also highlight challenges facing antifungal nanoparticles and discuss possible future research opportunities in this field. STATEMENT OF SIGNIFICANCE: Fungal infections pose a growing threat to human health and livelihood. The rapid spread of resistance to current antifungal drugs has led to an urgent need to develop alternative antifungals. Nanoparticles have many properties that could make them useful antimycotic agents. To the authors' knowledge, there is no published review so far that has comprehensively summarized the current development status of antifungal inorganic nanomaterials, so we decided to fill this gap. In this review, we discussed the state-of-the-art research on antifungal inorganic nanoparticles including metal, metal oxide, transition-metal dichalcogenides, and inorganic non-metallic particle systems. Future directions for the design of inorganic nanoparticles with higher antifungal efficacy and lower toxicity are described as a guide for further development in this important area.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: